Journal of Endocrinology · 2009 · 17 citations · 46 references
Life SciencesBiochemistryEndocrinologyLipid BiochemistryMetabolic RegulationMetabolismBile Acid BiosynthesisCholesterol MetabolismInsulin ResistanceLipid MetabolismLipoprotein MetabolismMetabolic SyndromeBile Acid Synthesis RegulationCholesterol 7 Alpha-hydroxylase RegulationCholesterol AccumulationHepatic Lipid AccumulationHigh-density Lipoprotein MetabolismLipid Metabolism EffectsLipoprotein Lipase FunctionLipoprotein Metabolism Regulation
Insulin resistance and dyslipidemia are both considered to be risk factors for metabolic syndrome. Low levels of IGF1 are associated with insulin resistance. Elevation of low-density lipoprotein cholesterol (LDL-C) concomitant with depression of high-density lipoprotein cholesterol (HDL-C) increase the risk of obesity and type 2 diabetes mellitus (T2DM). Liver secretes IGF1 and catabolizes cholesterol regulated by the rate-limiting enzyme of bile acid synthesis from cholesterol 7alpha-hydroxylase (CYP7A1). NO-1886, a chemically synthesized lipoprotein lipase activator, suppresses diet-induced insulin resistance with the improvement of HDL-C. The goal of the present study is to evaluate whether NO-1886 upregulates IGF1 and CYP7A1 to benefit glucose and cholesterol metabolism. By using human hepatoma cell lines (HepG2 cells) as an in vitro model, we found that NO-1886 promoted IGF1 secretion and CYP7A1 expression through the activation of signal transducer and activator of transcription 5 (STAT5). Pretreatment of cells with AG 490, the inhibitor of STAT pathway, completely abolished NO-1886-induced IGF1 secretion and CYP7A1 expression. Studies performed in Chinese Bama minipigs pointed out an augmentation of plasma IGF1 elicited by a single dose administration of NO-1886. Long-term supplementation with NO-1886 recovered hyperinsulinemia and low plasma levels of IGF1 suppressed LDL-C and facilitated reverse cholesterol transport by decreasing hepatic cholesterol accumulation through increasing CYP7A1 expression in high-fat/high-sucrose/high-cholesterol diet minipigs. These findings indicate that NO-1886 upregulates IGF1 secretion and CYP7A1 expression to improve insulin resistance and hepatic cholesterol accumulation, which may represent an alternative therapeutic avenue of NO-1886 for T2DM and metabolic syndrome.
46
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
Robert H. Eckel, KGMM Alberti, Scott M. Grundy et al. · The Lancet · 2010 · 6.3K citations
The Pathobiology of Diabetic Complications
Michael Brownlee · Diabetes · 2005 · 5.3K citations · Full text
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Timothy T. Lu, Makoto Makishima, Joyce J. Repa et al. · Molecular Cell · 2000 · 1.5K citations · Full text
Molecular physiology of reverse cholesterol transport.
C J Fielding, P E Fielding · Journal of Lipid Research · 1995 · 1.4K citations · Full text